Institute for Translational Research

UNT Health Science Center

James Hall, PhD
- James.Hall@unthsc.edu
- Graduate School of Biomedical Sciences
- Institute for Translational Research - Professor
- Pharmacology & Neuroscience - Professor
Person: Faculty
20062021
Leigh Johnson, PhD
- Leigh.Johnson@unthsc.edu
- Graduate School of Biomedical Sciences
- Institute for Healthy Aging - Member
- Institute for Translational Research - Assistant Professor
- Pharmacology & Neuroscience - Assistant Professor
Person: Faculty
20112021
Sid O'Bryant, PhD
- Sid.OBryant@unthsc.edu
- Graduate School of Biomedical Sciences
- Institute for Healthy Aging - Member
- Institute for Translational Research - Professor and Executive Director
- Pharmacology & Neuroscience - Professor
Person: Faculty
20032021

7 Active
29 Finished

Confidential
O'Bryant, S.
1/08/19 → 31/07/22
Project: Research
Blood-Brain Barrier Disruption as a Biomarker for Peroperative Neurocognitive Disorders: Cognitive Recovery after Elective Surgery (CREATES) Study
O'Bryant, S. & Hall, J.
Rhode Island Hospital
1/05/19 → 29/02/24
Project: Research
Detection of Elder Abuse Through Emergency Care Technicians (DETECT)
O'Bryant, S.
University of Texas HSC at Houston
15/09/18 → 31/05/23
Project: Research

6693 Citations
42 h-Index
147 Article
17 Review article
2 Chapter
2 Comment/debate
More
- 2 Editorial
- 2 Short survey

A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community-dwelling Mexican Americans and non-Hispanic Whites: A method for increasing representation of diverse populations in clinical research
for the HABLE Study Team, 2021, (Accepted/In press) In: Alzheimer's and Dementia.
Research output: Contribution to journal › Article › peer-review

Open Access
A Precision Medicine Approach to Treating Alzheimer's Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials
O'Bryant, S. E., Zhang, F., Petersen, M., Johnson, L., Hall, J. & Rissman, R. A., 2021, In: Journal of Alzheimer's Disease. 81, 2, p. 557-568 12 p.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
Aptamarker prediction of brain amyloid-β status in cognitively normal individuals at risk for Alzheimer’s disease
the INSIGHT-preAD study group & Alzheimer Precision Medicine Initiative (APMI), Jan 2021, In: PLoS ONE. 16, 1 January, e0243902.
Research output: Contribution to journal › Article › peer-review

Open Access